4//SEC Filing
Turgeon Joseph W. 4
Accession 0001209191-21-013275
CIK 0000831547other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:00 PM ET
Size
13.8 KB
Accession
0001209191-21-013275
Insider Transaction Report
Form 4
Turgeon Joseph W.
Chief Commercial Officer
Transactions
- Award
Common Stock, $0.001 par value
2021-02-18+278,090→ 648,119 total - Sale
Common Stock, $0.001 par value
2021-02-22$3.73/sh−7,500$27,975→ 633,362 total - Sale
Common Stock, $0.001 par value
2021-02-19$3.64/sh−7,257$26,394→ 640,862 total - Award
Stock Option (Right to Buy)
2021-02-18+337,079→ 337,079 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (337,079 underlying) - Award
Stock Appreciation Right
2021-02-18+792,135→ 792,135 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (792,135 underlying)
Holdings
- 1,538(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (4)
- [F1]One third of the aggregate amount of restricted shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F2]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
- [F3]One third of the aggregate amount of option shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F4]One third of the aggregate amount of stock appreciation rights shall vest on each of February 18, 2022, 2023 and 2024, respectively.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001574659
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:00 PM ET
- Size
- 13.8 KB